View all IME CME

Share a PER® activity with your colleagues or friends. Connect with the PER® social network.



Accreditation/ Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.


Resources

PER Pulse™ Recap
The 12th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®, which was held February 20, 2016, featured internationally recognized experts in dermatologic malignancies discussing best practices and new approaches for the treatment of patients with melanoma.


Acknowledgment of Commercial Support

This activity is supported by educational grants from Genentech, Inc, Incyte Corporation, and Novartis Pharmaceuticals Corporation.


Community Practice Connections™: 12th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®


Release Date: April 29, 2016
Expiration Date: April 29, 2017
Media: Internet - based

Activity Overview

Community Practice Connections™: 12th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® consists of a series of interactive clinical vignettes, short video interviews of leading experts in melanoma and other cutaneous malignancies, and short summaries of clinical data related to these malignancies. The video interviews address decision points in the clinical vignettes, as well as questions commonly faced in the community oncology practice setting.

CME Activity Table of Contents

  • A Patient With BRAF Mutation-Positive Melanoma and a Poor Performance Status
  • A Patient With BRAF Mutation-Positive Melanoma and a Good Performance Status
  • A Patient With BRAF Wild-Type Melanoma
  • A Patient With Basal Cell Carcinoma

Instructions For This Activity & Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, "educational content/video" will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.


Target Audience

This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with melanoma and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of melanoma and other cutaneous malignancies may also participate.


Educational Objectives

At the conclusion of this activity, you should be better prepared to:
  • Choose treatment based on patient characteristics, such as age and performance status
  • Assess the roles of regional therapies, targeted therapies, and immunotherapies in the treatment of patients
  • Review strategies for mitigating and managing adverse events related to therapy
  • Describe current and emerging strategies for individualizing therapy
  • Evaluate emerging clinical data regarding new regional therapies, targeted therapies, and immunotherapies in treating melanoma and other cutaneous malignancies


Faculty, Staff, and Planners' Disclosures

Faculty

Michael B. Atkins, MD
Deputy Director
Georgetown-Lombardi Comprehensive Cancer Center
Professor of Oncology and Medicine (Hematology/Oncology)
Georgetown University School of Medicine
Washington, DC
 

Omid Hamid, MD
Chief, Translational Research & Immuno-Oncology
Director, Cutaneous Malignancies - The Angeles Clinic and Research Institute
Director, Experimental Therapeutics, Cedars-Sinai Medical Care Foundation
Los Angeles, CA
 

Jason Luke, MD, FACP
Assistant Professor of Medicine
The University of Chicago Medicine
Chicago, IL



Jeffrey S. Weber, MD, PhD
Laura and Isaac Perlmutter Cancer Center
Professor of Medicine
NYU Langone Medical Center
New York, NY



The following individuals have no relevant financial relationships with commercial interests:

The staff of Physicians’ Education Resource®, LLC

Michael B. Atkins, MD -- Consultant: Bristol-Myers Squibb, Merck, Novartis, Roche, Pfizer, Nektar Therapeutics, Amgen; Jason Luke, MD, FACP -- Consultant: Amgen, Array BioPharma; Omid Hamid, MD -- Grant/Research Support: Bristol-Myers Squibb, GlaxoSmithKline, Merck, Incyte, Roche, Eisai, MedImmune, Merck Serono, Pfizer, Novartis, Immunocore; Consultant: Bristol-Myers Squibb, Genentech, Merck, Amgen, Roche; Speakers’ Bureau: Bristol-Myers Squibb, Genentech, GlaxoSmithKline; Jeffrey Weber, MD, PhD -- Grant/Research Support to Moffitt: Bristol-Myers Squibb, GlaxoSmithKline, Merck, Incyte, Genentech; Consultant: Bristol-Myers Squibb, GlaxoSmithKline, Merck, Incyte, Genentech, AstraZeneca, Medivation; Shareholder: Altor BioScience, Celldex Therapeutics, cCAM Biotherapeutics, CytomX Therapeutics


Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of Physicians' Education Resource®, LLC, (PER®) to ensure fair balance, independence, objectivity, and scientific rigor in all of our CME/CE activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as a part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.


Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical education purposes only, and is not meant to substitute for the independent medical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of Physicians' Education Resource®, LLC, or any of the companies that provided commercial support for this activity.


Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise




Calendar of Events
Filter By